CYCLESSA desogestrel and ethinyl estradiol United States - English - NLM (National Library of Medicine)

cyclessa desogestrel and ethinyl estradiol

organon usa inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.1 mg

ORTHO CEPT desogestrel and ethinyl estradiol United States - English - NLM (National Library of Medicine)

ortho cept desogestrel and ethinyl estradiol

janssen pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.15 mg

KIMIDESS- desogestrel and ethinyl estradiol kit United States - English - NLM (National Library of Medicine)

kimidess- desogestrel and ethinyl estradiol kit

par pharmaceutical - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - kimidess® is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. table ii: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, united states.    % of women experiencing an unintended pregnancy within the first year of use   % of women continuing use at one year 3 adapted from hatcher et al., 1998, ref#1. 1 among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience

DESOGEN desogestrel and ethinyl estradiol United States - English - NLM (National Library of Medicine)

desogen desogestrel and ethinyl estradiol

organon usa inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.15 mg

AZURETTE desogestrel/ethinyl estradiol and United States - English - NLM (National Library of Medicine)

azurette desogestrel/ethinyl estradiol and

watson pharma, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.15 mg

RECLIPSEN desogestrel and ethinyl estradiol United States - English - NLM (National Library of Medicine)

reclipsen desogestrel and ethinyl estradiol

actavis pharma, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.15 mg

Cyred (Desogestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg) United States - English - NLM (National Library of Medicine)

cyred (desogestrel and ethinyl estradiol tablets usp, 0.15 mg/0.03 mg)

rpk pharmaceuticals, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - cyred® (desogestrel and ethinyl estradiol tablets usp, 0.15 mg/0.03 mg) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with desogestrel and ethinyl estradiol tablets, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. table 1:  percentage of women experiencing an unintended pregnancy during the first year of typic

Cerazette 75 µg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cerazette 75 µg tabl.

organon belgium bv-srl - desogestrel 0,075 mg - tablet - 75 µg - desogestrel 75 µg - desogestrel

Desoceane 75 µg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

desoceane 75 µg film-coat. tabl.

gedeon richter plc - desogestrel 0,075 mg - film-coated tablet - 75 µg - desogestrel 75 µg - desogestrel